CliniContact
CLINICONTACTBridge
Book a demo →
Community outreach for clinical trials

The communities who know your patients — connected to your trial.

Behind every clinical trial is a community of patients, advocates, clinicians, and support networks who already know each other. CliniContact Bridge reaches them with warm, indication-specific outreach — and you watch it all happen in a live portal, grounded in real engagement numbers and U.S. Census data, not vendor promises.

Live client portalYour study, in real time
Census-groundedReal data · honest numbers
From $1,200/mo3-month engagement

Patients aren't on a list. They're in a community.

For most conditions — especially the harder-to-recruit ones — patients live within networks of people who already understand what they're going through. The advocacy lead who's been there for fifteen years. The specialist clinic across town. The Facebook group with 400 quiet members. These are the connections that move a trial forward, and they can't be bought from a database.

The truth

The right outreach builds trust

A generic "we have a clinical trial" message gets ignored — and rightly so. Patients and the people who care about them respond to outreach that names their condition, respects their time, and shows up like a real conversation, not a mass email.

The truth

Communities are how trials get found

Once an advocacy group or specialist trusts your trial, the word travels in ways no ad campaign can replicate. One trusted referral often opens a door that hundreds of cold contacts couldn't.

The truth

You only get one shot at goodwill

The same advocates and specialists show up across multiple trials. Treat them well and they become long-term partners; treat them as a list and they stop opening your emails — for this trial and the next one.

Don't take our word for it. Watch the work.

Every Bridge engagement includes a live client portal — not a monthly PDF. These are real screens from a Bridge study dashboard (demo study, fictional partners), showing exactly what you log into from day one.

Honest by design

Every rate in the portal counts unique partner organizations — a clinic that received three follow-ups still counts once. And we never describe a community's population as people "reached." The numbers stay defensible, because you may have to defend them to your sponsor or your IRB.

Bridge is the community-outreach stage of your CliniContact study.

CliniContact runs the full recruitment journey across connected products — from study setup through participant enrollment. Bridge is the stage where your trial reaches into the communities that already know your patients. Your team focuses on the science. We focus on the people who can help patients find you.

Where Bridge fits in the CliniContact suite
Horizon
Launch
Bridge
Smart Screener
Vision

Three things, done well.

You tell us about your trial. We bring decades of community-outreach experience and a CliniContact team that's run this work across hundreds of indications. The outcome is real conversations with the people who can help your trial succeed.

01

We learn your indication

Every condition has its own network of advocates, specialists, and support communities. We start by understanding yours — who's trusted, who's connected, and where the people who care about your patients spend their time.

02

We reach out with care

Outreach drafted from your own study materials, tuned to each community we contact. No mass blasts, no copy-paste — every message lands like a real human took the time to write it, because someone did.

03

We nurture the relationships

Replies are read, classified, and acted on quickly. Interested partners are followed up. Questions are answered. The communities we connect with stay warm — for this trial and the ones that come after it.

Reach you can defend. Diversity you can measure.

Most vendors hand you a big number and hope you don't ask where it came from. Bridge computes its reach estimates from public, citable sources — and because community outreach is how trials become representative, the underrepresented share of every community in your footprint is a first-class metric, not an afterthought.

Populations

U.S. Census ACS

Every community in your outreach footprint carries its real Census population — including the underrepresented share — so geographic and diversity reach are measured, not guessed.

Epidemiology

Cited prevalence only

Your condition's prevalence is researched from sources like NIH, CDC, and NORD — with the citation attached. If a figure can't be cited, the portal shows no estimate rather than an invented one.

Providers

NPI Registry & HRSA

Clinician and community-health-center sourcing draws on the CMS NPI Registry and HRSA health-center data — real institutions, real locations, real specialties.

Your study

Live engagement data

Sends, opens, and replies counted once per partner organization, statuses that always add up, and an AI analyst that answers demographic questions from live Census tables — with citations.

Every trial has a network. We help yours find it.

No two indications have the same community. A rare-disease trial lives or dies on the support of a handful of patient foundations; a cardiology study reaches into entirely different specialist networks. Bridge meets your trial where it actually is.

Patient communities

Advocacy & support groups

Disease-specific advocacy organisations, patient foundations, and online support communities — the places people turn to when they're newly diagnosed and looking for help, hope, and other people who understand.

Clinical communities

Clinicians & specialists

The doctors and care teams who already see your patients — primary care, sub-specialists, centres of excellence. The people patients trust most when deciding whether a trial is right for them.

Local communities

Regional & cultural networks

For studies that need representation across geography, ethnicity, or community context — local health workers, faith-based networks, community health centres, and the trusted voices that shape participation.

The relationships compound

The advocacy lead who refers a patient to your trial today is the same advocacy lead who will refer to your next trial — if we treat the relationship right. CliniContact protects every connection we build, across every study we work on.

You're partnering with a team, not buying a list.

No vendor can honestly promise a number of referrals at the start of an engagement — every indication is different, and the communities reveal themselves as the work unfolds. What we can commit to is how we work, what you'll see, and how we'll show up.

Scope

A clear plan, agreed upfront

We agree the scope of the engagement together — geographic reach, the kinds of communities we'll connect with, the materials we'll use. No surprises, and no scope creep on either side.

Visibility

A live portal, not a monthly PDF

Your outreach health score, every partner organization with its fit score and reasoning, a census-grounded reach map, referral results, and an AI analyst — updated continuously. Plus a monthly written summary and a quarterly review.

Care

Real people, looking after the work

You always have a named CliniContact contact who knows your study. Replies are read and acted on quickly, and the communities we connect with are treated like the long-term relationships they are.

What you can expect from us

An engagement that's transparent about how it's going, honest when something isn't working, and committed to protecting the relationships your trial depends on. The work is real, and so is the partnership.

Three tiers. By indication complexity.

Bridge is priced by how hard the indication is to work — not by how much we promise to deliver. Every tier includes the full Bridge engagement, your CliniContact team, and the live client portal. We work in 3-month engagements so the relationships have room to take hold.

Tier 01 · Common

Common

$1,200per month
3-month engagement
Typical indications
Diabetes, hypertension, common chronic conditions, large primary-care populations.
  • Indication research & community mapping
  • Personalised, indication-specific outreach
  • Reply handling & follow-up
  • Community relationship care
  • Live client portal with reach & diversity analytics
  • Monthly written summary
  • A named CliniContact contact
Best fit when partners are widely distributed across primary care and large advocacy bodies.
Tier 03 · Niche

Niche

$1,800per month
3-month engagement
Typical indications
Rare disease, ultra-orphan conditions, paediatric trials, highly localised patient populations.
  • Deep indication research
  • Patient foundation & registry connection
  • Centre-of-excellence outreach
  • Reply handling & follow-up
  • Community relationship care
  • Live client portal with reach & diversity analytics
  • A named CliniContact contact
Best fit when the patient population is small and concentrated — and the people who know them are foundations, registries, and centres of excellence.
Predictable pricing, by design

A flat monthly engagement means we can focus on the right communities for your trial — not on chasing volume to hit referral counts. You know your cost upfront, and we're free to do the work the way it should be done.

Questions sponsors ask first.

If we haven't covered something, reach out — we'll answer directly before you sign anything.

What exactly do I see in the client portal?
A live dashboard for each study: an outreach health score, open/reply rates counted per unique partner organization, a U.S. map of your footprint, a census-grounded reach estimate narrowed to your study's age and condition criteria, every partner organization with its fit score and reasoning, screener referral results, and an AI analyst you can ask questions in plain English. The videos above are real portal screens.
How does Bridge support diversity in recruitment?
Representation is measured, not implied. Every community in your outreach footprint carries its real U.S. Census demographics, the underrepresented share is a first-class metric on the dashboard, and the AI analyst answers demographic questions — like which states have the highest share of a specific population — from live Census tables with citations. That makes diversity-focused outreach plannable and reportable, not anecdotal.
Why don't you commit to a number of referrals?
Because honestly, no one can predict that at the start. Every indication has its own community, and the right partners reveal themselves once the work begins. What we commit to is how we work — the scope of the engagement, how often you'll see updates, and the care we take with every relationship. That's the part we control, and it's the part that delivers results worth talking about.
Will the same advocacy groups and clinicians be contacted across multiple trials?
No. CliniContact carefully manages the relationships we build, and we never bombard the same person across studies. The advocacy lead who refers a patient to your trial today should be ready and willing to refer to your next trial too — and protecting that goodwill is part of how we work.
Do you contact patients directly?
No. Bridge is for community outreach — the advocates, clinicians, and support networks who know your patients and can refer them to your trial. Patients are reached at the next stage of the journey through CliniContact's screener, which handles patient prequalification.
What does outreach actually look like?
Warm, personal, and indication-specific. Outreach is drafted from your study materials and tuned for each kind of community we connect with — an advocacy organisation gets a different tone than a sub-specialty clinic. You see and approve the templates before anything goes out.
Why a 3-month engagement?
Community outreach takes time to do well. The first few weeks are about understanding your indication and the people in it; the months that follow are when relationships develop and referrals start to flow. Three months is the minimum window where the work pays off — anything shorter and you're stopping before the relationships have had a chance to take hold.
Which tier fits our study?
Common is for high-prevalence conditions where partners are broadly distributed across primary care and large advocacy bodies. Specialty is for sub-specialty conditions — common oncology, MS, IBD, hep — where the communities are more focused. Niche is for rare disease, paediatric, and ultra-orphan conditions where the network is small and concentrated. If you're not sure, book a call — we'll match the tier in 15 minutes.
Where does Bridge fit alongside other CliniContact products?
Bridge is the community-outreach stage of the CliniContact suite — Horizon → Launch → Bridge → Smart Screener → Vision. Each product handles a different stage of the recruitment journey, and Bridge is where your trial connects with the people who can help patients find you. You can run Bridge as part of a full CliniContact engagement or on its own.

Ready to connect your trial to its community?

You've seen the portal. Book a 30-minute call — we'll talk through your indication, match your study to the right tier, and show you the dashboard live with your study's profile in mind.